Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

These stories show how volatility in global markets is pushing manufacturers to make painful workforce decisions.

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

Haleon Pakistan has announced a fresh investment of $12 million to expand its manufacturing capacity, focusing on scaling up ...

The melanoma market is predicted to surge during the forecast period (2025–2034) owing to factors, as the increasing incidence of melanoma, the launc ...